Elevance Health stock trades EUR 368.45 as weekly high reaches EUR 371.95
Published on 10/10/2026 at 10:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Elevance Health stock was at EUR 368.45 in weekend trading on October 10, 2026.
- The week's indicated high was EUR 371.95 and low was EUR 352.60.
- Elevance Health scheduled third-quarter results for October 21, 2026.
Elevance Health stock was at EUR 368.45 in weekend trading at Lang & Schwarz at 10:42 a.m. CEST on October 10, 2026, up 0.46 percent versus the close of EUR 366.75 at Lang & Schwarz on October 9, 2026. Market context: Market report S&P 500.
The week in figures
The latest weekend indication was EUR 368.45. The week's indicated high was EUR 371.95, while the indicated low was EUR 352.60. The comparison close for the weekend session was EUR 366.75 at Lang & Schwarz on October 9, 2026.
The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CEST is shown by the continuously updated real-time quote of Elevance Health stock.
Chronology of the week
On October 1, 2026, Elevance Health announced that its affiliated health plans would offer 2027 Medicare Advantage plans. The related Medicare Annual Enrollment Period runs from October 15 through December 7, 2026, according to the company release.
On October 5, 2026, Elevance Health said it would release third-quarter 2026 results at 6:00 a.m. EDT on October 21, followed by a management conference call at 8:30 a.m. EDT, as stated in the company release.
Dates of the coming week
The next dated item is October 15, 2026, when Medicare's Annual Enrollment Period begins. Elevance Health's third-quarter results and conference call are scheduled for October 21, 2026, according to the company's October 5 release.
